ClassID:

21574

A61K51/083 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide

Recent Application in this class:
#1
20260151517
2026-06-04

SOMATOSTATIN RECEPTOR-TARGETING RADIOPHARMACEUTICALS AND USES THEREOF

#2
20260137818
2026-05-21

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#3
20260102526
2026-04-16

177LUTETIUM-DOTA-TATE FORMULATIONS

#4
20260097140
2026-04-09

Radiolabelled Compounds

#5
20260053960
2026-02-26

DIMERIC RADIOPHARMACEUTICALS, COMPOSITIONS THEREOF AND USES THEREOF

#6
20260053959
2026-02-26

METHODS FOR LARGE SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES

#7
20260053958
2026-02-26

HALOGENATED SOMATOSTATIN ANALOGS WITH MULTIPLE SOMATOSTATIN RECEPTOR SUBTYPE SELECTIVITY

#8
20250388523
2025-12-25

18F-LABELED PEPTIDE LIGANDS USEFUL IN PET AND CERENKOV LUMINESCENE IMAGING

#9
20250387523
2025-12-25

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

#10
20250345468
2025-11-13

COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER

#11
20250345438
2025-11-13

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#12
20250313579
2025-10-09

LIGAND COMPOUNDS COMPRISING A CHELATING GROUP AS A BRIDGING GROUP

#13
20250255993
2025-08-14

STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND USES THEREOF

#14
20250222146
2025-07-10

Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof

#15
20250099634
2025-03-27

METHOD OF TREATING CANCER

#16
20250057998
2025-02-20

Radiopharmaceutical and Methods

#17
20250025583
2025-01-23

METHOD OF TREATMENT OF NEUROENDOCRINE TUMORS

#18
20250009916
2025-01-09

COMBINATION THERAPY FOR TREATING LUNG CANCER

#19
20250009912
2025-01-09

COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES

#20
20240350679
2024-10-24

RADIOLABELING AND FORMULATION FOR SCALE UP OF 64Cu-DOTATATE

#21
20240317780
2024-09-26

RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF

#22
20240299596
2024-09-12

METHODS AND MATERIALS FOR COMBINING BIOLOGICS WITH MULTIPLE CHELATORS

#23
20240285817
2024-08-29

BISPIDINE DERIVATIVES AND THE USE THEREOF

#24
20240277876
2024-08-22

PET IMAGING TRACERS

#25
20240207458
2024-06-27

TARGETED ALPHA PARTICLE THERAPY FOR SOMATOSTATIN RECEPTOR 2 POSITIVE NEUROENDOCRINE TUMORS AND METASTASES

#26
20240189460
2024-06-13

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#27
20240181094
2024-06-06

[161Tb]-BASED RADIOPEPTIDES

#28
20240173441
2024-05-30

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#29
20240172953
2024-05-30

HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#30
20230414796
2023-12-28

COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER

#31
20230382819
2023-11-30

PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS

#32
20230293736
2023-09-21

[161 tb]-based radiopeptides

#33
20230265165
2023-08-24

TRANSDUCED T CELLS EXPRESSING HUMAN SSTR2 AND APPLICATION THEREOF

#34
20230218764
2023-07-13

SOMATOSTATIN RECEPTOR-BASED CANCER THERAPY

#35
20230165981
2023-06-01

[161Tb]-BASED RADIOPEPTIDES

#36
20220370622
2022-11-24

Pharmaceutical compositions and related methods of delivery

#37
20220370621
2022-11-24

Pharmaceutical compositions and related methods of delivery

#38
20220202966
2022-06-30

POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING

#39
20220143227
2022-05-12

Method of Treatment of Neuroendocrine Tumors That Over-Express Somatostatatin Receptors

#40
20220096646
2022-03-31

SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF

#41
20220080059
2022-03-17

Radiolabeling and formulation for scale up of Cu-DOTATATE

#42
20220072166
2022-03-10

METHOD OF TREATMENT OF NEUROENDOCRINE TUMORS

#43
20220062446
2022-03-03

DUAL MODE 18F-LABELLED THERANOSTIC COMPOUNDS AND USES THEREOF

#44
20220062386
2022-03-03

Methods for imaging and treatment of somatostatin-receptor positive tumors

#45
20220054647
2022-02-24

SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF

#46
20220044835
2022-02-10

Processes and systems for producing and/or purifying gallium-68

#47
20220041649
2022-02-10

Methods for Synthesis of Radionuclide Complex

#48
20220008569
2022-01-13

PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS

#49
20220008565
2022-01-13

Enhanced in Vivo Targeting of Site-Specific Drugs

#50
20210379213
2021-12-09

Stable, concentrated radionuclide complex solutions

#51
20210346527
2021-11-11

Combination Therapy

#52
20210316019
2021-10-14

Methods for Synthesis of Radionuclide Complex

#53
20210309721
2021-10-07

I DOMAIN CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO ICAM-1

#54
20210308287
2021-10-07

Method for extraction and purification of 68GA

#55
20210228749
2021-07-29

Compositions for chelating metals at low temperatures

#56
20210128758
2021-05-06

Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use

#57
20200397906
2020-12-24

Pharmaceutical compositions and related methods of delivery

#58
20200317588
2020-10-08

F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging

#59
20200268914
2020-08-27

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

#60
20200238249
2020-07-30

Microfluidic cassette for synthesizing a radio-tracer and method of synthesizing a radio-tracer with such a cassette

#61
20200181238
2020-06-11

Transduced T cells expressing human SSTR2 and application thereof

#62
20200179514
2020-06-11

PHTHALOCYANINE PROBES AND USES THEREOF

#63
20200155714
2020-05-21

DUAL-TARGET IMAGING MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF

#64
20200131224
2020-04-30

Methods for Synthesis of Radionuclide Complex

#65
20200121813
2020-04-23

Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors

#66
20200038512
2020-02-06

Tumor treatment methods using cells that localize to the tumor

#67
20200030467
2020-01-30

Stable, concentrated radionuclide complex solutions

#68
20200030466
2020-01-30

Stable, concentrated radionuclide complex solutions

#69
20200017573
2020-01-16

I domain chimeric antigen receptor specific to ICAM-1

#70
20190336623
2019-11-07

Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes

#71
20190321497
2019-10-24

PET tracer for imaging of neuroendocrine tumors

#72
20190262460
2019-08-29

SSTR-targeted conjugates and particles and formulations thereof

#73
20190192700
2019-06-27

ANTICANCER THERAPY

#74
20190083664
2019-03-21

PET tracer for imaging of neuroendocrine tumors

#75
20190038758
2019-02-07

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#76
20180339048
2018-11-29

Therapeutic and Diagnostic Probes

#77
20180243369
2018-08-30

Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy

#78
20180221499
2018-08-09

SSTR-targeted conjugates and particles and formulations thereof

#79
20180193495
2018-07-12

POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING

#80
20180185524
2018-07-05

Method of Treatment of Neuroendocrine Tumors That Over-Express Somatostatatin Receptors

#81
20180125856
2018-05-10

USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS

#82
20180066037
2018-03-08

Transduced T cells expressing human SSTR2 and application thereof

#83
20180066035
2018-03-08

I domain chimeric antigen receptor specific to ICAM-1

#84
20180008716
2018-01-11

Somatostatin receptor-based cancer therapy

#85
20170304471
2017-10-26

Anticancer therapy

#86
20170014536
2017-01-19

Tin-117m somatostatin receptor binding compounds and methods

#87
20160333068
2016-11-17

Compositions and methods for imaging cancer

#88
20160263260
2016-09-15

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

#89
20160213793
2016-07-28

Somatostatin analogs with inhibitory activity to growth hormone release

#90
20160158159
2016-06-09

Pharmaceutical compositions and related methods of delivery

#91
20160045626
2016-02-18

Methods and Compositions for Improved Labeling of Targeting Peptides

#92
20160008495
2016-01-14

Metallocene compounds and labeled molecules comprising the same for in vivo imaging

#93
20150374819
2015-12-31

Phthalocyanine probes and uses thereof

#94
20150343084
2015-12-03

Therapeutic and diagnostic probes

#95
20150196673
2015-07-16

Anticancer therapy

#96
20150133634
2015-05-14

Kit and method for producing a radiopharmaceutical

#97
20150104381
2015-04-16

Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors

#98
20150031631
2015-01-29

Pharmaceutical compositions and related methods of delivery

#99
20140377177
2014-12-25

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#100
20140369928
2014-12-18

Automatic synthesizer apparatus for producing radiopharmaceutical tumor imaging agent Gallium-68-DOTATATE and method thereof

#101
20140341807
2014-11-20

Pet tracer for imaging of neuroendocrine tumors

#102
20140314670
2014-10-23

CLICKED SOMATOSTATIN CONJUGATED ANALOGS FOR BIOLOGICAL APPLICATIONS

#103
20140179598
2014-06-26

Somatostatin analogs with inhibitory activity to growth hormone release

#104
20140178300
2014-06-26

Theranostic imaging agents and methods of use

#105
20140147381
2014-05-29

89ZR COMPOUNDS, TO INCLUDE SOMATOSTATIN, APPARATUS AND PRODUCTS COMPRISING SUCH COMPOUNDS, METHODS OF MAKING SAME, AND METHODS OF USING SAME FOR RADIO IMAGING AND/OR TREATMENT

#106
20140140923
2014-05-22

Tin-117m somatostatin receptor binding compounds and methods

#107
20140105819
2014-04-17

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

#108
20130343990
2013-12-26

Radiolabelled octreotate analogues as PET tracers

#109
20130287681
2013-10-31

Somatostatin receptor-based cancer therapy

#110
20120282178
2012-11-08

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#111
20120263645
2012-10-18

RADIOLABELED COMPOUND DIRECTABLE IN VIVO TO TARGET TISSUE AND USE THEREOF

#112
20120177571
2012-07-12

PANCREATIC ENDOCRINE CELL INDICATING AGENT AND UTILIZATION OF SAME

#113
20120134920
2012-05-31

Methods and compositions for improved F labeling of proteins, peptides and other molecules

#114
20120093886
2012-04-19

Pharmaceutical compositions and related methods of delivery

#115
20120076727
2012-03-29

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

#116
20120009229
2012-01-12

Pharmaceutical compositions and related methods of delivery

#117
20110280801
2011-11-17

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#118
20110257095
2011-10-20

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#119
20110243845
2011-10-06

Somatostatin analogs with inhibitory activity to growth hormone release

#120
20110110854
2011-05-12

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#121
20100105627
2010-04-29

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#122
20100008857
2010-01-14

Hexatriene-β-carbonyl compound

#123
20090324497
2009-12-31

Tc and Re labeled radioactive glycosylated octreotide derivatives

#124
20090246130
2009-10-01

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#125
20090155166
2009-06-18

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#126
20090137909
2009-05-28

Method for imaging and treating organs and tissues

#127
20080247947
2008-10-09

High dose 111In-pentetreotide therapy of neuroendocrine tumors

#128
20070066516
2007-03-22

Compounds comprising cyclized somatostatin receptor binding peptides

#129
20070041902
2007-02-22

Somatostatin analogs with inhibitory activity to growth hormone release

#130
20070031329
2007-02-08

Method of obtaining gallium-68 and use thereof and device for carrying out said method

#131
20070027307
2007-02-01

Microwave method for preparing radiolabelled gallium complexes

#132
20070025910
2007-02-01

Anticancer therapy

#133
20060263295
2006-11-23

Chelators for radioactively labeled conjugates comprising a stabilizing sidechain

#134
20060233704
2006-10-19

Prochelator for the preparation of radiometal labeled molecules having improved biological properties

#135
20060165593
2006-07-27

Tc and Re labeler radioactive glycosylated octreotide derivatives

#136
20060155107
2006-07-13

SSTR1-selective analogs

#137
20060040324
2006-02-23

Methods for making metallopeptides and metallopeptide libraries

#138
20050226813
2005-10-13

Labelled somatostatin analogs backbone cyclized through metal complexation

#139
20050118099
2005-06-02

Thiol-mediated drug attachment to targeting peptides

#140
20050070470
2005-03-31

Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof